bWe examined the utility of a single matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry method for the identification of security-sensitive biological agents (risk group 3 bacterial pathogens). The goal was 2-fold: to verify a method for inclusion into our scope of accreditation, and to assess the biological safety of extractions. We developed our sample flow to include a tube-based chemical extraction, followed by filtration, before processing on MALDI-TOF MS instruments in a containment level 2 laboratory.
Matrix-assisted laser desorption-ionization time of flight mass spectrometry (MALDI-TOF MS) is a rapid, robust, and cost-effective technology, which is emerging as a routine bacterial identification method in clinical diagnostic laboratories (1-3). Despite its utility, there are concerns with the safety of sample processing and the quality of spectral databases for the identification of security-sensitive biological agents (SSBAs). As our laboratory predominately works with SSBA bacterial pathogens (the risk group 3 [RG-3] pathogens: Francisella tularensis, Yersinia pestis, Bacillus anthracis, Brucella species, and Burkholderia pseudomallei), our goal was to verify the usefulness and safety of a MALDI-TOF MS method for inclusion into our scope of accreditation (ISO 17025). We chose to pursue a full-tube-based protein extraction method involving cellular disruption and filtration, rather than the direct-colony plate (smear) method (4, 5), in an effort to mitigate the risk of viable organisms.Over a period of 1 year, 146 bacterial samples (including 57 SSBA samples; Table 1) were processed as previously described (6). The bacteria were previously identified by standard genotypic and phenotypic methods. In brief, all cultures were chemically extracted in a microcentrifuge tube using 70% ethanol, 70% formic acid, and acetonitrile, and all SSBA bacteria were extracted in a biosafety level 3 (BSL-3) laboratory. SSBA extracts from sporeforming bacteria were filtered through a 0.1 M microcentrifuge filtration unit (EMD Millipore, Etobicoke, Ontario, Canada), as recommended by Dauphin and Bowen (7). The viability of the extract was performed by inoculating 10% of the extract onto both sheep's blood agar (SBA) (or cysteine heart agar [CHA] for F. tularensis) and into 2 ml of tryptic soy broth (TSB), and incubating at 35°C and 5% CO 2 for 48 h. After 48 h, the TSB was further subcultured to SBA or CHA and monitored for an additional 72 h. Any bacterial growth was tested with agent-specific assays to rule out the SSBA, indicating a contaminant. After a lack of growth was confirmed, extracts were removed from the BSL-3 laboratory, and 1.5 l of the extract was applied (at a minimum of four replicate spots) to an MSP-96 MALDI target plate (Bruker Daltonics, East Milton, Ontario, Canada), with an overlay of 1.5 l of ␣-cyano-4-hydroxycinnamic acid (CHCA) matrix solution (50% acetonitrile and 2.5% trifluoroacetic acid). Mass spectra were acquired with the FlexControl software (version 3.0...